Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 1/20 | 0.48 |
| ▸ | CCR8 | P51685 | 1/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.47 |
| ▸ | GRM5 | P41594 | 2/20 | 0.44 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | NR1I3 | Q14994 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16189352 | 0.95 | CCR1 (0.50) | CCR1CCR8CYP2A6GRM5TGFBR1 | |
| SCHEMBL16189409 | 0.93 | L3MBTL1 (0.48) | CCR1CCR8CYP2A6GRM5TGFBR1 | |
| SCHEMBL17932800 | 0.93 | L3MBTL1 (0.48) | CCR1CCR8CYP2A6GRM5TGFBR1 | |
| SCHEMBL16189074 | 0.93 | CCR1 (0.52) | CCR1CCR8CYP2A6GRM5TGFBR1 | |
| SCHEMBL16189355 | 0.93 | CCR1 (0.52) | CCR1CCR8CYP2A6GRM5TGFBR1 | |
| SCHEMBL16189305 | 0.92 | MEN1 (0.49) | CCR1CCR8CYP2A6GRM5TGFBR1 | |
| SCHEMBL19009464 | 0.92 | MEN1 (0.49) | CCR1CCR8CYP2A6GRM5TGFBR1 | |
| SCHEMBL19009474 | 0.92 | L3MBTL1 (0.50) | CCR1CCR8CYP2A6GRM5TGFBR1 | |
| SCHEMBL16189316 | 0.91 | CCR1 (0.58) | CCR1CCR8CYP2A6GRM5TGFBR1 | |
| SCHEMBL16189265 | 0.89 | MEN1 (0.49) | CCR1CCR8CYP2A6GRM5TGFBR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11329230-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-05-10 | — | — | US | disclosed |
| US-20170317294-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-11-02 | — | — | US | disclosed |
| US-20170317294-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11329230-B2 | Organic light-emitting device | EML4, SUN2, TRPA1 | CCR1 2925/4885CCR8 2616/4885CYP2A6 1675/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.